Diagonal Bio AB (DIABIO) — Cash Flow Reinvestment Rate

Latest as of March 2024: 0.08x

Diagonal Bio AB (DIABIO) has a Cash Flow Reinvestment Rate of 0.08x as of March 2024, reinvesting Skr541.00K (capex Skr0.00 plus investments Skr-541.00K) from operating cash flow of Skr6.57 Million. Explore Diagonal Bio AB (DIABIO) cash flow conversion to assess how effectively this company generates cash.

Reinvestment Rate

0.08x

(Capex + Investments) / Operating CF

Total Reinvested

Skr541.00K

Capex + Investments

Operating Cash Flow

Skr6.57 Million

SEK

Capital Expenditures

Skr0.00

SEK

Diagonal Bio AB Cash Flow Reinvestment Rate (2020–2020)

Historical reinvestment intensity for Diagonal Bio AB across 1 annual periods. Explore DIABIO operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Diagonal Bio AB (2020–2020)

Year-by-year capital reinvestment analysis for Diagonal Bio AB. For live market cap and broader valuation context, see DIABIO market cap overview.

Year	Reinvestment Rate	Total Reinvested (SEK)	Operating CF	Capex	YoY Change
2020	0.00x	Skr0.00	Skr226.67K	Skr0.00	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow